Behind the Mystery: Health Innovations
March 15, 2021
Learning more about rare diseases
On this episode of The Balancing Act, stay tuned for a new edition of Behind the Mystery.
ENPP1 deficiency is a devastating, life-long disease, making a rapid and correct diagnosis critical.
SeaSpine, a medtech company, designs, develops, and delivers the most advanced spinal technologies for surgeons and their patients.
Related Stories
PROMOTED
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
PROMOTED
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
PROMOTED
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.
Comments